1. Home
  2. BOX vs ARQT Comparison

BOX vs ARQT Comparison

Compare BOX & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Box Inc.

BOX

Box Inc.

HOLD

Current Price

$24.14

Market Cap

3.4B

Sector

Technology

ML Signal

HOLD

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

HOLD

Current Price

$23.31

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOX
ARQT
Founded
2005
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
BOX
ARQT
Price
$24.14
$23.31
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$35.57
$34.00
AVG Volume (30 Days)
2.0M
909.3K
Earning Date
05-26-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
88.79
EPS
0.58
N/A
Revenue
$506,142,000.00
$376,072,000.00
Revenue This Year
$9.41
$34.85
Revenue Next Year
$8.15
$29.39
P/E Ratio
$42.47
N/A
Revenue Growth
26.98
91.34
52 Week Low
$21.34
$12.42
52 Week High
$38.80
$31.77

Technical Indicators

Market Signals
Indicator
BOX
ARQT
Relative Strength Index (RSI) 51.88 47.76
Support Level $23.17 $22.56
Resistance Level $24.55 $23.46
Average True Range (ATR) 0.79 0.92
MACD 0.14 -0.10
Stochastic Oscillator 79.10 35.33

Price Performance

Historical Comparison
BOX
ARQT

About BOX Box Inc.

Box is a cloud-based content management platform that provides storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file, sync, and share provider. Over time, it built out and acquired workflow and security tools to evolve the pure-play FSS business into a content management business. Most recently, Box has been pursuing an AI-powered, intelligent content management strategy that can allow for metadata extraction and workflow automation.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: